A. Fienberg

发表

Dopamine and cAMP-Regulated Phosphoprotein 32 kDa Controls Both Striatal Long-Term Depression and Long-Term Potentiation, Opposing Forms of Synaptic Plasticity

P. Greengard, P. Calabresi, B. Picconi, 2000, The Journal of Neuroscience.

Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons

P. Greengard, A. Nairn, H. Hemmings, 1999, Nature.

D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade.

P. Greengard, D. Surmeier, A. Fienberg, 2000, Journal of neurophysiology.

Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine

P. Greengard, A. Nairn, P. Svenningsson, 2002, Nature.

Regulation of Phosphorylation of the GluR1 AMPA Receptor in the Neostriatum by Dopamine and Psychostimulants In Vivo

P. Greengard, A. Nairn, A. Fienberg, 2000, The Journal of Neuroscience.

Protein phosphatase 1 modulation of neostriatal AMPA channels: regulation by DARPP–32 and spinophilin

P. Greengard, A. Nairn, A. Fienberg, 1999, Nature Neuroscience.

A Network of Control Mediated by Regulator of Calcium/Calmodulin-Dependent Signaling

P. Greengard, A. Nairn, D. Surmeier, 2004, Science.

Diverse Psychotomimetics Act Through a Common Signaling Pathway

P. Greengard, P. Svenningsson, A. Fienberg, 2003, Science.

Regulation of AMPA receptor dephosphorylation by glutamate receptor agonists

P. Greengard, A. Nairn, A. Fienberg, 2003, Neuropharmacology.

Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32.

David G Standaert, A. Fienberg, D. Standaert, 2004, Molecular pharmacology.

DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens

A. Fienberg, G. Snyder, S. Schreiber, 2002, Nature Neuroscience.

DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task

P. Greengard, C. Heyser, A. Fienberg, 2000, Brain Research.

DARPP-32: Regulator of the Efficacy of Dopaminergic Neurotransmission

Paul Greengard, Steven E. Hyman, James P. O'Callaghan, 1998 .

The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses.

P. Greengard, A. Fienberg, J. Spiess, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Isolation, chromosomal localization, and nucleotide sequence of the human HOX 1.4 homeobox.

A. Fienberg, F. Ruddle, A. Ferguson-Smith, 1989, Genomics.

Homeobox-containing Genes: Implications for Pattern Formation During Embryonic Development in the Mouse

A. Fienberg, K. Schughart, F. Ruddle, 1989 .

Synapsins as mediators of BDNF-regulated neurotransmitter release

P. Greengard, A. Fienberg, A. Czernik, 1999 .

Developmental regulation of polyamine metabolism in growth and differentiation of carrot culture

A. Fienberg, Z. R. Sung, W. Lubich, 1984, Planta.

Disruption of orofacial movement topographies in congenic mutants with dopamine D5 but not D4 receptor or DARPP-32 transduction ‘knockout’

D. Grandy, A. Fienberg, D. Sibley, 2006, European Neuropsychopharmacology.

Gαolf Levels Are Regulated by Receptor Usage and Control Dopamine and Adenosine Action in the Striatum

A. Fienberg, J. Girault, C. Le Moine, 2001, The Journal of Neuroscience.

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia

W H Wong, K. Davis, J. Buxbaum, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of Stanniocalcin 2, a Novel Target of the Mammalian Unfolded Protein Response with Cytoprotective Properties

A. Fienberg, C. Thompson, A. Hakim, 2004, Neurobiology of Aging.

, Isabella Response with Cytoprotective Properties Target of the Mammalian Unfolded Protein Characterization of Stanniocalcin 2 , a Novel

A. Fienberg, C. Thompson, A. Hakim, 2004 .

Topographical Assessment of Ethological and Dopamine Receptor Agonist-Induced Behavioral Phenotype in Mutants with Congenic DARPP-32 ‘Knockout’

P. Greengard, A. Fienberg, J. Waddington, 2003, Neuropsychopharmacology.

Effects of Chronic ‘Binge’ Cocaine Administration on Plasma ACTH and Corticosterone Levels in Mice Deficient in DARPP-32

P. Greengard, A. Fienberg, M. Kreek, 1999, Neuroendocrinology.

A DNA-binding activity, TRAC, specific for the TRA element of the transferrin receptor gene copurifies with the Ku autoantigen.

A. Fienberg, F. Ruddle, L. Hunihan, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Forebrain overexpression of CK1δ leads to down-regulation of dopamine receptors and altered locomotor activity reminiscent of ADHD

P. Greengard, A. Nairn, A. Fienberg, 2010, Proceedings of the National Academy of Sciences.

Developmental biology of embryogenesis from carrot culture

A. Fienberg, Z. R. Sung, G. Giuliano, 1984, Plant Molecular Biology Reporter.

Ethologically Based Resolution of D2-Like Dopamine Receptor Agonist-versus Antagonist-Induced Behavioral Topography in Dopamine- and Adenosine 3′,5′-Monophosphate-Regulated Phosphoprotein of 32 kDa “Knockout” Mutants Congenic on the C57BL/6 Genetic Background

P. Greengard, A. Fienberg, J. Waddington, 2004, Journal of Pharmacology and Experimental Therapeutics.

Dopamine D 1 vs D 5 receptor-dependent induction of seizures in relation to DARPP-32 , ERK 1 / 2 and GluR 1-AMPA signalling

A. Fienberg, D. Sibley, G. Fisone, 2015 .

Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling

P. Greengard, A. Fienberg, D. Sibley, 2008, Neuropharmacology.

Neuronal and behavioural abnormalities in striatal function in DARPP‐32‐mutant mice

P. Greengard, A. Fienberg, N. Hiroi, 1999, The European journal of neuroscience.

Motivational Effects of Ethanol in DARPP-32 Knock-Out Mice

P. Greengard, A. Fienberg, F. O. Risinger, 2001, The Journal of Neuroscience.

A Dopamine/D1 Receptor/Protein Kinase A/Dopamine- and cAMP-Regulated Phosphoprotein (Mr 32 kDa)/Protein Phosphatase-1 Pathway Regulates Dephosphorylation of the NMDA Receptor

P. Greengard, A. Fienberg, R. Huganir, 1998, The Journal of Neuroscience.

Homeo box genes in murine development.

C. P. Hart, A. Fienberg, F. Ruddle, 1987, Current topics in developmental biology.

DARPP-32 Phosphorylation Opposes the Behavioral Effects of Nicotine

A. Fienberg, N. Hiroi, F. Guan, 2005, Biological Psychiatry.

Dopamine D1 Receptor‐Induced Gene Transcription Is Modulated by DARPP‐32

P. Greengard, P. Svenningsson, A. Fienberg, 2000, Journal of neurochemistry.

261. DARPP-32: Regulator of the efficacy of dopaminergic neurotransmission

P. Greengard, A. Fienberg, 1998, Biological Psychiatry.

Molecular characterization of recombinant mouse adenosine kinase and evaluation as a target for protein phosphorylation.

A. Nairn, A. Fienberg, J. Bibb, 2004, European journal of biochemistry.

Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons

A. Fienberg, A. Nishi, G. Snyder, 2012, Neuropharmacology.

D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons.

P. Greengard, A. Fienberg, J. Feng, 1999, Proceedings of the National Academy of Sciences of the United States of America.

DARPP-32 mediates serotonergic neurotransmission in the forebrain

P. Greengard, P. Svenningsson, A. Fienberg, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac)

P. Greengard, P. Svenningsson, A. Fienberg, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Cannabinoid Action Depends on Phosphorylation of Dopamine- and cAMP-Regulated Phosphoprotein of 32 kDa at the Protein Kinase A Site in Striatal Projection Neurons

P. Greengard, P. Svenningsson, A. Fienberg, 2005, The Journal of Neuroscience.

Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or Inhibitor 1

P. Greengard, A. Fienberg, P. Allen, 2002, Biological Psychiatry.

The DARPP-32/protein phosphatase-1 cascade: a model for signal integration 1 Published on the World Wide Web on 22 January 1998. 1

Angus C Nairn, Paul Greengard, Gilberto Fisone, 1998, Brain Research Reviews.

Methylphenidate restores novel object recognition in DARPP-32 knockout mice

C. Heyser, A. Fienberg, Caitlyn H. McNaughton, 2013, Behavioural Brain Research.

Synapsins as mediators of BDNF-enhanced neurotransmitter release

P. Greengard, A. Fienberg, A. Czernik, 2000, Nature Neuroscience.

Inhibitor-1 Is Not Required for the Activation of Glycogen Synthase by Insulin in Skeletal Muscle*

P. Greengard, A. Fienberg, P. Allen, 1999, The Journal of Biological Chemistry.

Phosphorylation of DARPP-32 at Threonine-34 is Required for Cocaine Action

P. Greengard, A. Nairn, P. Svenningsson, 2006, Neuropsychopharmacology.

Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32.

Paul Greengard, Carlos Cepeda, Michael S Levine, 2002, Journal of neurophysiology.

A review of the pharmacology and clinical profile of lumateperone for the treatment of schizophrenia.

A. Fienberg, G. Snyder, K. Vanover, 2021, Advances in pharmacology.

Phylogenetically conserved CK-II phosphorylation site of the murine homeodomain protein Hoxb-6.

P. Greengard, A. Nairn, A. Fienberg, 1999, The Journal of experimental zoology.

Requirement for DARPP-32 in progesterone-facilitated sexual receptivity in female rats and mice.

P. Greengard, A. Fienberg, P. Allen, 2000, Science.

The DARPP-32 knockout mouse

P. Greengard, A. Fienberg, 2000, Brain Research Reviews.

Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia

P. Greengard, A. Nairn, H. Hemmings, 2000, Neuropharmacology.

INCREASED BLOOD PRESSURE AND LOSS OF ANP-INDUCED NATRIURESIS IN MICE LACKING DARPP-32 GENE

P. Greengard, A. Fienberg, A. Aperia, 2001, Clinical and experimental hypertension.

An Adenosine-Mediated Glial-Neuronal Circuit for Homeostatic Sleep

A. Fienberg, J. Bibb, N. Dale, 2016, The Journal of Neuroscience.

Phosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32‐dependent pathways: evidence from PDE1B‐DARPP32 double‐knockout mice

P. Greengard, A. Fienberg, C. Vorhees, 2006, Genes, brain, and behavior.

Psychotherapy supported by drug treatment is the prescription for children and adolescents with post-traumatic stress disorder

A. Fienberg, G. Snyder, S. Schreiber, 2002 .

Dopamine Modulation of Membrane Excitability in Striatal Spiny Neurons is Altered in DARPP-32 Knockout Mice

Anthony A Grace, A. Grace, A. Fienberg, 2003, Journal of Pharmacology and Experimental Therapeutics.

Requirement for DARPP‐32 in mediating effect of dopamine D2 receptor activation

P. Greengard, A. Nairn, A. Fienberg, 1999, The European journal of neuroscience.

DARPP-32 promoter directs transgene expression to renal thick ascending limb of loop of Henle.

A. Fienberg, M. Ehrlich, L. Daly, 1995, The American journal of physiology.

Developmental regulation of polyamine metabolism in growth and differentiation of carrot culture

A. Fienberg, W. Lubich, Z. Sung, 1984, Planta.